Neuphoria Therapeutics Inc.
NEUP
Rank in Stocks
#29263
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$3.92
Last synced: 2026-07-31
Market Cap
$21.16M
Change (1 day)
-0.13%
Change (1 year)
60,767.52%
Country
US
Trade Neuphoria Therapeutics Inc. (NEUP)
Category
Healthcare
Market Capitalization of Neuphoria Therapeutics Inc.(NEUP)
Market Cap: $21.16M
As of October 2026 Neuphoria Therapeutics Inc. has a market cap of $21.16M. This makes Neuphoria Therapeutics Inc. the world's 29263rd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Neuphoria Therapeutics Inc. from 1999 to 2026
NEUP compared with Top 5 Most Popular stocks
